DrugPatentWatch Database Preview
OCUSERT PILO-40 Drug Profile
or, see our see our flat-rate plans
When do Ocusert Pilo-40 patents expire, and when can generic versions of Ocusert Pilo-40 launch?
The generic ingredient in OCUSERT PILO-40 is pilocarpine. There are twelve drug master file entries for this compound. Additional details are available on the pilocarpine profile page.
Summary for OCUSERT PILO-40
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 30 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,924 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | OCUSERT PILO-40 at DailyMed |
Medical Subject Heading (MeSH) Categories for OCUSERT PILO-40
Synonyms for OCUSERT PILO-40
| (+)-Pilocarpine |
| (3S-cis)-3-Ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone |
| (3S-cis)-3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2(3H)-furanone |
| (3S,4R)-3-Ethyl-4-((1-methyl-1H-imidazol-5-yl)methyl)dihydrofuran-2(3H)-one |
| (3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]dihydrofuran-2(3H)-one |
| (3S,4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]oxolan-2-one |
| (3S,4R)-3-ethyl-4-[(1-methylimidazol-5-yl)methyl]-3,4,5-trihydrofuran-2-one |
| (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one |
| (3S,4R)-3-ethyl-4-[(3-methylimidazol-4-yl)methyl]tetrahydrofuran-2-one |
| (3S,4R)-3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-2(3H)-furanone |
| 01MI4Q9DI3 |
| 092P137 |
| 2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S-cis)- |
| 2(3H)-Furanone, 3-ethyldihydro-4-((1-methyl-1H-imidazol-5-yl)methyl)-, (3S,4R)- |
| 2(3H)-Furanone, 3-ethyldihydro-4-[(1-methyl-1H-imidazol-5-yl)methyl]-, (3S,4R)- |
| 3-Ethyl-4-(3-methyl-3H-imidazol-4-ylmethyl)dihydrofuran-2-one |
| 3-ethyl-4-[(3-methylimidazol-4-yl)methyl]oxolan-2-one |
| 91484-73-0 |
| 92-13-7 |
| AB00053525_28 |
| AB00053525_29 |
| AB00053525-27 |
| AC1L1LEF |
| Adsorbocarpine |
| AI3-50523 |
| AK116461 |
| Akarpine |
| AKOS016010311 |
| Almocarpine |
| Amistura P |
| AN-42585 |
| AX8148055 |
| BDBM50008072 |
| beta-Pilocarpine hydrochloride |
| BIDD:GT0217 |
| BPBio1_000548 |
| BRD-K85090592-008-05-2 |
| BSPBio_000498 |
| BSPBio_002191 |
| C07474 |
| CAS-92-13-7 |
| CCG-205031 |
| CHEBI:8207 |
| CHEMBL550 |
| D00525 |
| D06HLY |
| DB01085 |
| Diocarpine (TN) |
| DivK1c_000358 |
| DSSTox_CID_1162 |
| DSSTox_GSID_21162 |
| DSSTox_RID_75984 |
| DTXSID1021162 |
| EINECS 202-128-4 |
| Epicar |
| GTPL305 |
| HE020263 |
| HE415620 |
| HMS2089K17 |
| HSDB 3163 |
| IDI1_000358 |
| Imidazole-5-butyric acid, alpha-ethyl-beta-(hydroxymethyl)-1-methyl-, gamma-lactone |
| isopilocarpine |
| Isopto carpine |
| Isopto carpine (TN) |
| Isoptocarpine |
| KB-207616 |
| KBio1_000358 |
| KBio2_001587 |
| KBio2_004155 |
| KBio2_006723 |
| KBio3_001691 |
| KBioGR_000956 |
| KBioSS_001587 |
| Lopac0_000950 |
| Lopac0_000960 |
| LS-187208 |
| LS-7661 |
| MCULE-2634151840 |
| MFCD00153042 |
| Mi-Pilo |
| Minims Pilocarpine |
| Miocarpine |
| Miocarpine (TN) |
| NCGC00023339-03 |
| NCGC00023339-06 |
| NCGC00023339-07 |
| NCGC00023339-08 |
| NCGC00023339-09 |
| NCGC00023339-10 |
| NCGC00023339-11 |
| NCGC00023339-12 |
| NCGC00023339-13 |
| NCGC00023339-14 |
| NCGC00023339-16 |
| NCI60_004403 |
| NINDS_000358 |
| NSC5746 |
| Ocu-Carpine |
| ocucarpine |
| Ocusert |
| Ocusert P 20 |
| Ocusert pilo |
| Ocusert pilo-20 |
| Ocusert pilo-20 (TN) |
| P.V. Carpine Liquifilm |
| Pilagan |
| Pilocarpin |
| pilocarpine |
| Pilocarpine (JAN/USP) |
| Pilocarpine (TN) |
| Pilocarpine [USAN:BAN:JAN] |
| Pilocarpine [USP:BAN:JAN] |
| Pilocarpine chloride |
| Pilocarpine HCl |
| Pilocarpine monohydrochloride |
| Pilocarpine Mononitrate, (3S-cis)-Isomer |
| Pilocarpine nitrate salt |
| Pilocarpine-d3 HCl (deuterated) |
| Pilocarpine, Monohydrochloride, (3S-cis)-Isomer |
| Pilocarpol |
| Pilokarpin |
| Pilokarpol |
| Pilopine HS (TN) |
| Piloptic-1 |
| Piloptic-1/2 |
| Piloptic-2 |
| Piloptic-3 |
| Piloptic-4 |
| Piloptic-6 |
| Pilostat |
| Prestwick0_000449 |
| Prestwick1_000449 |
| Prestwick2_000449 |
| Prestwick3_000449 |
| QCHFTSOMWOSFHM-WPRPVWTQSA-N |
| Salagen |
| Salagen (TN) |
| SBB012409 |
| SBI-0050924.P004 |
| Scheinpharm (TN) |
| SCHEMBL15146 |
| SDCCGMLS-0003164.P005 |
| SPBio_001287 |
| SPBio_002437 |
| Spectrum_001107 |
| Spectrum2_001284 |
| Spectrum3_000546 |
| Spectrum4_000478 |
| Spectrum5_001379 |
| Spersacarpine |
| ST069319 |
| STOCK1N-18408 |
| Syncarpine |
| Timpilo (TN) |
| Tocris-0694 |
| Tox21_110887 |
| Tox21_110887_1 |
| UNII-01MI4Q9DI3 |
| ZINC75008 |
US Patents and Regulatory Information for OCUSERT PILO-40
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Akorn | OCUSERT PILO-40 | pilocarpine | INSERT, EXTENDED RELEASE;OPHTHALMIC | 017548-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
or, see our see our flat-rate plans
or, see our see our flat-rate plans
